How to Read a Startup Term Sheet:
A Guide for Founders

You just got your first term sheet. The valuation looks amazing: $20 million for a company that was worth nothing a year and a half ago. Every instinct says sign it now, before the investor changes their mind.

Wait. Below that big number sit a dozen clauses that decide the things that actually matter: whether you stay in control of your company, and whether you walk away rich or with nothing when it sells. Most founders never learn to read a startup term sheet properly. This guide will fix that.

Here is the key thing to understand up front. A term sheet is mostly “non–binding,” which sounds harmless. But once you sign it, the deal is basically locked. Trying to change terms later makes you look like you are negotiating in bad faith. So the time to get it right is now, before you sign. Below, we walk through every clause and show you exactly where founders give away more than they meant to.

What Is a Term Sheet

A term sheet is a short document that outlines the key terms of an investor’s proposed investment in your company. It covers valuation, ownership, control, investor rights, and other major deal points that will later be reflected in the final financing documents.

Although most term sheet provisions are technically non-binding, two clauses are usually binding immediately upon signing:

• Confidentiality restricts you from sharing the terms of the offer.
• Exclusivity (No-Shop) prevents you from negotiating with other investors for a specified period.

Because final agreements are typically drafted to match the term sheet, founders should negotiate carefully before signing.

Why the Term Sheet Matters So Much

The term sheet establishes the economic and control framework of your investor relationship. While founders often focus on valuation, the clauses governing liquidation preferences, dilution, board control, and investor rights can have a much greater impact on both ownership and eventual exit proceeds. 

A higher valuation does not always mean a better deal if the underlying terms heavily favor investors.

The Money Terms: Valuation and Investment

This section determines how much the investor invests and what ownership stake they receive.

• Pre-money valuation: Your company’s value before the investment.
• Post-money valuation: Pre-money valuation plus the new investment.

Example:

• Investment: $5 million
• Pre-money valuation: $15 million
• Post-money valuation: $20 million
• Investor ownership: 25% ($5M ÷ $20M)

A key issue to watch for is the option pool shuffle. Investors often require a share pool for future employees, but they may ask for it to be created from the pre-money valuation. This means the dilution comes primarily from existing shareholders rather than the investor.

Always confirm:

• Is the option pool included in the pre-money valuation?
• Or is it created after the investment as part of the post-money valuation?

Liquidation Preferences: Who Gets Paid First When You Sell

A liquidation preference decides who gets paid first and how much, when your company is sold or shut down. It is one of the most important money terms in the whole document, and one of the easiest to overlook.

Here are the three versions you will run into:

Aim for 1x non-participating. When an investor stacks a participating preference on top of a 2x or 3x multiple, you can walk away with almost nothing even if the company sells for a good price. For a full walkthrough with exit math, see our guide on liquidation preferences.

Vesting: Earning Founder Equity Over Time

The standard vesting schedule is four years with a one-year cliff:

• No shares vest during the first year.
• At the one-year mark, 25% of shares vest.
• The remaining shares vest monthly over the next three years.
• If a founder leaves early, unvested shares are typically repurchased by the company.

Another important term is acceleration, which determines what happens to unvested shares after an acquisition:

• Single-trigger acceleration: shares vest when the company is sold.
• Double-trigger acceleration: shares vest only if the company is sold and the founder is terminated or removed.

These provisions can significantly affect founder ownership and exit proceeds.

Control Terms: Who Runs the Company

The term sheet determines not only economics but also control. Two provisions deserve particular attention:

• Board seats: Define how much influence investors have over major company decisions. Giving investors too many seats can reduce founder control.
• Protective provisions: Give investors veto rights over specific actions, such as raising capital, issuing new shares, or selling the company.

Some investor protections are standard, but founders should review these provisions carefully to ensure they do not unnecessarily restrict the company’s ability to operate and grow.

Investor Rights: The Ongoing Strings Attached

A term sheet also gives investors a set of rights that stick around long after they wire the money. The common ones:

• Pro rata rights: the right to put more money into future rounds so they can keep their ownership percentage from shrinking.
• Information rights: the right to get regular financial reports and updates from you.
• Drag-along rights: if the majority votes to sell the company, small shareholders have to go along with it. This stops one holdout from blocking a sale.
• Right of first refusal (ROFR): before you sell your shares to an outsider, you have to offer them to the investor first.
• Co-sale (tag-along) rights: if you sell some of your shares, the investor can sell some of theirs on the same terms.

None of these is automatically bad, but each one takes a little flexibility away from you. Know exactly what you are giving up before you agree.

Anti-Dilution: What Happens If Your Next Round Is Lower

Sometimes a company has to raise its next round at a lower price than the last one. That is called a “down round.” Anti-dilution protection is the investor’s safety net for that situation: if new shares get sold cheaper than what they paid, the term gives them extra shares to make up for it. There are two versions, and the difference is huge for you:

Push for broad-based weighted average and refuse full ratchet if you can.

For Biotech and Life Sciences Founders

If you are building a biotech or life sciences company, your startup term sheet will have a few extra terms that software founders rarely see. They come from the high cost and long timelines of developing drugs and devices:

• IP representations and warranties matter more here. Investors want proof that your company owns the core science, not the founding scientists personally, and not a former university lab. A gap here can sink the whole deal.
• Milestone-based tranches mean the money comes in stages, released as you hit clinical or regulatory goals, instead of all at once. It protects the investor but ties your cash to results you cannot fully control.

We have seen biotech founders agree to milestone tranches with strict definitions, then hit a cash gap when a trial ran a few months late. Because these rounds are big and risky, investors often push harder on preferences and control, so careful review matters even more.

Warning Signs to Watch For

Some terms are a clear signal that the deal leans hard in the investor’s favor. Be on alert if you see:

• Participating liquidation preferences (the “double dip”).
• 2x or 3x liquidation preferences that pay investors several times their money before you get anything.
• Full ratchet anti-dilution, the harsh version that hits you hardest in a down round.
• A large option pool taken entirely out of the pre-money valuation.
• Broad protective provisions that let investors veto everyday decisions.
• Founder re-vesting with no acceleration if the company is sold or you are let go.

Any one of these can be negotiated. But if you see several stacked together, slow down and look hard before you respond. An investor waving a high valuation while burying three of these in the fine print is often offering you a worse deal than someone with a lower number and clean terms.

Your Checklist Before You Sign

Patience protects founders far more than excitement does. Before you sign anything, run through this list:

• Negotiate every term. Almost everything is on the table, and investors expect you to push back.
• Look past the valuation. Work out what you would actually take home under the real terms, not just the headline number.
• Run the exit math. Figure out who gets paid what if the company sells high, sells low, or sells somewhere in between.
• Get a startup lawyer. Free templates like the NVCA model legal documents are a starting point, but a good attorney catches what templates miss.
• Do not let a deadline rush you. An “exploding offer” built to make you sign before you can think is itself a warning sign.

How Crowley Law Helps with Term Sheet Review

Crowley Law LLC reviews and negotiates term sheets for life sciences and technology startups. We help founders understand every clause – from valuation and liquidation preferences to board control and anti-dilution – before they sign away rights they cannot easily recover.

Reviewing your term sheet with experienced counsel helps protect founder economics, preserve control, and avoid terms that look harmless but cost millions at exit. Contact Crowley Law to speak with a startup attorney, whether you need a single term sheet review or a full financing strategy.

Contact Us | Schedule a Consultation

Frequently Asked Questions (FAQs)